Marcia Angell Quotes
The pharmaceutical industry isn't the only place where there's waste and inefficiency and profiteering. That happens in much of the rest of the health care industry.
Angell, Marcia. Interview. Frontline: The Other Drug War, PBS, 19 June 2003.
The immediate trigger for this statement was the Mylan Company’s price increase of 500 percent for Epi-pens which people—frequently children—needed to carry to contact a bad allergic reaction that would other wise put them into anaphylactic shock which could be fatal. One of the reasons the company gave for the increase was that their marketing costs were very high. The practice of paying physicians to use a drug and then give testimonials and pitch the drug had long been controversial, but in 2016 the public learned that the practice was much more widespread than anyone had known. Making the situation worse was the fact that physicians would prescribe the drug for their patients and had no obligation to tell the patient or his/her family that he was being paid by the drug company. The Congress held hearings but did nothing at the time.
Others while conceding that corporate involvement accounted for the extremely high costs of American pharmaceuticals and medical devices and equipment, argue that the companies have produced many innovations in addition to the research the government has paid for, and would not agree with Washington that the involvement was all “disastrous.”
Although extremely conservative, Paul was opposed to giving corporations a cut of economic activity just to say that it was private and not public of government run. The corporate HMOs and managed care organizations claimed that they are performing a quality control and money saving service, but there were non profit organizations that performed the functions just as well and did not add on a profit fee for themselves,
Marcia Angell is an American physician, author, and the first woman to serve as editor-in-chief of the New England Journal of Medicine. She is currently a Senior Lecturer in the Department of Global Health and Social Medicine at Harvard Medical School in Boston, Massachusetts.